Company intelligence / Profile preview

VULM

Ownership: Private
Development stage: Other

Overview

VULM is an established Slovak pharmaceutical company with a global presence. It has been active since 1972 and focuses on research, development, and production of drugs (various forms), medical devices, food supplements, and cosmetics. The company operates modern EU GMP-compliant facilities for manufacturing non-sterile liquid, semi-solid/topical, and solid drug forms. Clinical results are not detailed publicly as the focus is on commercialized products rather than novel clinical-stage assets.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

Burow-VULM

Unknown

Partnerships

Collaborates with several internationally acknowledged foreign pharmaceutical companies and research institutions

Beyond the preview

Go deeper on VULM.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VULM.

Explore the full profile